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Results: Mean age was 59±12 years with xx (79%) men. Mean left ven-
tricular ejection fraction was 28±9% and mean arterial blood pressure was 
110±15/68±9 mmHg. During a mean follow up of 7 years, the composite 
outcome was observed for 71 (32.2%) patients. After multivariate analysis, 
NYHA class (I/II vs. III/IV) and 24h-BPV (> vs.<23 mmHg - mean median 
value) were found to be the two independent factors of survival with an odds 
ratio of 5.1 (95% IC: 3 - 8.8; p<0.01) and 1.8 (95% IC 1.1 - 2.9; p<0.02) 
respectively. 
Conclusion: In a population of CHF, high level of 24h-BPV (>23 mmHg) 
is a positive prognostic value for survival.
Kaplan-Meier curves: 24h - BPV  value impact on cumulative outcome
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Carvajal/Naxos syndrome secondary to Desmoplakin-dominant mu-
tation is associated with dilated cardiomyopathy, wolly hair, palmo-
plantar keratoderma and hypo/oligodontia
L Chalabreysse [Orateur] (1,4), F. Senni (1), P Bruyère (2), B Aime (1), 
C Ollagnier (1), A Bozio (3), Patrice Bouvagnet (1,3,4)
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(3) Service Cardiologie Pédiatrique, Hôpitaux de Lyon, Lyon, Lyon, 
France – (4) Université Bernard Lyon 1, EA 4171, Lyon, France
There is evidence that Carvajal (woolly hair, palmoplantar keratoderma 
and dilated cardiomyopathy) and Naxos (same hair and skin anomalies with 
¿ brofatty cardiomyocytes replacement in the right ventricle) syndromes are 
variable expressions of the same syndrome secondary to mutations in genes 
encoding proteins of the desmosome. We report an additional sign that might 
be helpful to cardiologists to establish the diagnosis.
The proband had 3 episodes of chest pain with transient ST elevation in 
leads V3-V4 and mild rise of troponin. He had LV diameter 64 mm with nor-
mokinetics and no coronary anomalies. He had good adaptation to physical 
activity but numerous premature beats disappearing during physical stress. He 
had palmoplantar keratoderma, woolly hair and was missing several molars.
A younger brother had 2 fainting episodes as he was 17. He had incomplete 
RBBB and dilated left ventricle with normokinetics. Four years later, he had 
shortness of breath with LV at 70 mm and EF at 20%. He had runs of ventri-
cular tachycardia. He received a heart graft. His heart had enlarged ventricles 
with ¿ brofatty replacement in the right ventricle. He had palmoplantar kerato-
derma, wolly hair and marked oligodontia with only 4 permanent molars and 
several persisting primary teeth.
The father who experienced several fainting spells had also a dilated car-
diomyopathy with the same skin, hair and teeth anomalies.
The desmoplakin (DSP) and plakoglobin (JUP) genes were screened for 
mutation and a single heterozygous mutation was found in the DSP gene: 
p.Ser597Leu. This residue is conserved across vertebrates and absent from 
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Early Repolarization associated with Primary Ventricular Fibrillation 
in Patients with Acute Coronary Syndrome
Linda Aissou [Orateur], Sarah Traulle, Astrid Delaverne, Jean-Sylvain 
Hermida, Anne-Lise Piriou, Genevieve Jarry, Astrid Delaverne, Laurent 
Leborgne, Maciej Kubala
CHU Amiens Sud, Cardiologie A, Amiens, France
Introduction: Early Repolarization (ER) is recognized as being the main 
indicator of new cardiac syndrome: the Early Repolarization Syndrome (ERS).
This new syndrome is the consequence of repolarization heterogeneity, which 
appears on healthy heart, lighting the mechanism of idiopathic Ventricular 
Fibrillation (VF). The presence of ER has also been detected on patients with 
heart disorders as Hypertrophic Obstructive Cardiomyopathy, Arrhythmogenic 
Right Ventricular Dysplasia, Ischemic Cardiopathy.
The Goal of this study was to determine prevalence of ER in patients who 
have VF during Acute Coronary Syndrome (ACS).
Methods: 53 patients, 41 men et 12 women, with a mean age of 52 years 
(+/- 10) presenting primary VF (< 48h after ACS) before revascularization 
of ACS have been included. We redraw cardio-vascular risk factors, history 
of ACS, ¿ rst measure of left ventricular fraction ejection (LVEF) at hos-
pital admission, electrocardiogram characteristics, previous treatments, myo-
cardial revascularization and we assessed prevalence of electrocardiographic 
ER.
The control group comprised 106 patients with ACS but without VF, who 
were matched for age and sex.
Results: ER was more common in cases than in controls (56.6% vs. 37.7%, 
p=0.02). Risk of primary VF during ACS was twice as important when ER 
was present (OR=2.37, IC [1.11-5.03]). LVEF<50% (60% vs. 27.6%, 
p<0.001) (OR=2.8, IC [1.25-6.31]) and QTc > 440 msec (45.3 vs. 20.8%, 
p=0.03) (OR=2.57, IC [1.17-5.65]), were also associated with a major risk of 
VF during ACS.
Conclusions: Among patients with a history of primary VF during ACS, 
there is an increased prevalence of ER as compared to patient with ACS 
without VF. 
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Prognostic value of 24h Blood Pressure variability in Chronic Heart 
Failure
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Purpose: Systolic blood pressure (SBP) level is positively correlated with 
survival in chronic heart failure (CHF) and negatively with arterial hyperten-
sion disease. A high level of blood pressure variability (BPV) represents, espe-
cially in arterial hypertension disease, a stronger cardiovascular risk. The aim 
of our study was to evaluate the prognostic impact of 24h-BPV level in CHF. 
Methods: We prospectively collected ambulatory monitoring blood pres-
sure (AMBP) of 288 patients hospitalized for CHF in the department of 
Cardiology of the University Hospital of Rangueil in Toulouse, France, 
between 1999 and 2006. Follow up was realized retrospectively using phy-
sician, patient or family phone contact during 2010. The composite outcome 
was de¿ ned by all causes of death, heart transplant, de¿ brillator shock and 
assistance device. 
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Our study investigates changes of membrane and sub-membrane structures 
induced by dystrophin-de¿ ciency in dilated cardiomyopathy.
We performed studies on ventricular cardiomyocytes from 13 month-
old mdx mice (animal model of DMD). The Scanning Ion Conductance 
Microscopy (Gorelik and al, 2006), which allows to observe membrane 
surface topography from living cells, and confocal images after staining with 
di-8-ANEPPS, showed surface membrane local and T-tubules disorganisation 
in mdx myocytes. DHPR immunolabelling corroborates these local disorgani-
sations. Loss of dystrophin seems disrupt actin myo¿ laments too, contrary to 
Bl10 ventricular myocytes.
In conclusion, our observations showed structural alterations of myocytes 
in dilated cardiomyopathy associated to dystrophin-de¿ ciency.
Finsterer J, Stöllberger C, Cardiology 2003;99:1-19.
Julia Gorelik et al, Cardiovascular Research 2006;72:422-9.
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Predictors of outcome in 369 patients with heart failure with preserved 
ejection fraction.
Hasnaa Salih [Orateur], Roger Kongo, Dounia Ghellab, Rachida Habbal, 
Leila Azzouzi, Ahmed Bennis
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Introduction:  A heart failure with preserved ejection fraction (HFPEF) 
is present in  half the patients with heart failure (HF); the prognosis in more 
recent studies has been shown to be essentially similar to that of systolic HF. 
The objective of our study is to de¿ ne the clinical, biological and echocardio-
graphic predictors of outcome in patients with HFPEF.
Material and methods: We included 1548 patients, admitted in Ibn Rochd 
Center of Cardiology from May 2006 to October 2010. HFPEF was de¿ ned 
as LVEF  45% and receiving a loop diuretic for breathlessness. All patients 
were evaluated clinically with monitoring of blood pressure (BP), 6 min walk 
test and electrocardiogram. Two-dimensional echocardiography and laboratory 
tests were performed in all patients.
Results: Of 1548 patients, 369 (24%) had HFPEF; the median age was 
66 years (42- 94) and 61.9% were men.  49.2% of the patients were hyperten-
sive and 33% were diabetic, and 61.9% were in NYHA class II, and 23.8% 
were in NYHA class III. The median of 6min walk test was 118m. the mean 
LVEF was 49% (45- 74). Hypertensive (44.4%) and Ischemic heart disease 
(17.46%) remain the two most frequent etiology. During a median follow 
up of 32 months, mortality was 16%. By univariable analysis, NHYA class; 
6min walk distance; atrial ¿ brillation and systolic pulmonary artery pressure 
(sPAP)   were associated with an adverse prognosis.
In multivariable analysis, increasing age, NYHA class, and renal failure 
were predictors of adverse prognosis; beta-blockers treatment, increasing Hb 
and female sex were predictors of a better outcome.
Conclusions: As several studies, clinical and biological variables were 
more powerful predictors  of outcome in HFPEF than echocardiographic 
variables which are recommended to identify diastolic function.
0138
Blood genes expression pro¿ les as markers for pre-heart failure detec-
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100 controls. The mutation was found in the 2 brothers, their father but absent 
from all other family members.
Conclusion: Heterozygous missense mutation in the DSP gene may result 
in chest pain, fainting episodes, dilated cardiomyopathy. The association of 
wolly hair, palmoplantar keratoderma or oligodontia may help in establishing 
the diagnosis of Carvajal/Naxos disease.
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LmnadelK32 heterozygous mice develop dilated cardiomyopathy that 
is not worsened by stress induced by exercise
Marie-Elodie Cattin [Orateur] (1), Arnaud Ferry (1), Alban Vignaud (1), 
Valérie Decostre (1), Shaida Varnous (1), Nathalie Mougenot (2), Yves 
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LMNA gene encodes lamins A/C, ubiquitous nuclear envelope proteins 
which play crucial role in maintaining nuclear shape and stiffness. When 
mutated, they lead to muscular and cardiac diseases maybe due, in part, 
to excessive mechanical stress sensitivity (“mechanical hypothesis”). The 
Emery-Dreifuss muscular dystrophy (EDMD) is a LMNA-related disorder. It 
associates muscular dystrophy and dilated cardiomyopathy (DCM).
To understand the pathophysiological mechanisms involved in a severe 
form of EDMD, we have deleted the lysine 32 in mouse Lmna gene. The 
aim of this study was to characterize the phenotype of the heterozygous (Het) 
mice LmnadelK32/+ and to investigate the sensitivity of myocardium to exercise.
Het mice show a progressive cardiac contractile dysfunction, evolving in 
DCM which leads to death between 35 and 70 weeks of age. 17 week-old 
Het and Wt mice were subjected to strenuous treadmill exercise for 5 weeks, 
5 days/week, 1h/day at speed ranging from 27 to 35 cm.s-1. Before the running 
protocol, cardiac function of Het mice was similar to Wt-littermates. After 
5 weeks, Het mice (trained (T) and sedentary (S)) showed decreased cardiac 
function compared to Wt mice (FS: 34±6,1% vs 40,4±4,7%) but cardiac func-
tion of Het-T did not differ from Het-S. There was no increase in heart-to-
body weight ratio and expression level of cardiac remodelling markers ANF 
and BNP as well as cellular and nuclear size of cardiomyocytes were similar 
in Het-T and Het-S mice. However, E-MHC was increased by 3-fold in Het 
vs Wt mice. All these parameters were not changed by training in Wt mice.
In conclusion, the LmnadelK32 mouse is the ¿ rst mouse model harbouring 
a heterozygous Lmna gene mutation which develops a phenotype affecting 
speci¿ cally the heart. The pathophysiological mechanisms of the DCM are 
still unclear but contradicting the “mechanical hypothesis”, the heart of Het 
mice is not more vulnerable to exercise-induced mechanical stress than their 
Wt-littermates.
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Local disorganisations of mdx myocytes membrane and sub-membrane 
in dilated cardiomyopathy associated to Duchenne Muscular Dystro-
phy
Mélanie Guef¿ er [Orateur], Charlotte Lorin, Jean-François Faivre, Patrick 
Bois, Christian Cognard, Stéphane Sebille
Institut de Physiologie et de Biologie Cellulaires CNRS UMR6187, Poitiers 
Cedex, France
Duchenne Muscular Dystrophy (DMD) is an X-linked myopathy. DMD is 
caracterised by muscular degeneration and ¿ brosis, which cause progressive, 
and then, total loss of ambulatory activity. Dystrophin forms bridge between 
the cytoskeletal F-actin and the extracellular matrix via the protein complex 
DAPC (Dystrophin-Associated Protein Complex). Loss of proteins scaffol-
ding, resulting of dystrophin absence, induced membrane instability involving 
functional alterations.
In spite of many studies and palliative treatments permitting an increased life 
expectancy, 90% of patients develop dilated cardiomyopathy (Finsterer and al, 
2003). Consequently, it is important to study cardiac alterations in DMD.
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lysis (PCA). To build an ALVD classifier model, we used the nearest 
centroid classification method (NCCM) with the ClaNC software package. 
Classification performance was determined using the leave-one-out cross-
validation method.
Results: Blood transcriptome analysis provided a speci¿ c molecular signa-
ture for ALVD which de¿ ned a model based on 7 genes capable of discri-
minating ALVD cases. Analysis of an ALVD patients validation group 
demonstrated that these genes are accurate diagnostic predictors for ALVD 
with 87% accuracy and 100% precision.
Discussion: These targets could serve to enhance the ability to ef¿ ciently 
detect ALVD by general care practitioners to facilitate preemptive initiation of 
medical treatment preventing the development of HF.
CHU Rangueil, Cardiologie, Toulouse, France – (6) INSERM U1027, CHU 
Rangueil, Cardiologie, 31432, France
Background: The preclinical stage of systolic heart failure (HF), known 
as asymptomatic left ventricular dysfunction (ALVD), is diagnosed only by 
echocardiography, frequent in the general population and leads to a high risk 
of developing severe HF. Large scale screening for ALVD is a dif¿ cult task 
and represents a major unmet clinical challenge that requires the determina-
tion of ALVD biomarkers.
Methods: 294 individuals were screened by echocardiography. We iden-
tified 9 ALVD cases out of 128 subjects with cardiovascular risk factors. 
White blood cell gene expression profiling was performed using pange-
nomic microarrays. Data were analyzed using principal component ana-
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